Product Information
VORICONAZOLE 50 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.8275 per EA under NDC 72578006206. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on May 24, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578006206
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VORICONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA206747FDA Approved
5/24/2016
TE Code
AB
On Market Since
4/16/2019
Pharmacological Classes
Price Statistics
The NADAC for VORICONAZOLE 50 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 41.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8275 per EA |
|---|---|
| All-time high | $0.8275 (Sep 30, 2026) |
| All-time low | $0.3779 (Mar 18, 2026) |
| 52-week high | $0.8275 |
| 52-week low | $0.3779 |
| Median price | $0.4379 |
| Average price | $0.4878 |
| Largest weekly change | +61.4% (Nov 20, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
voriconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VORICONAZOLE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VORICONAZOLE 50 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.8275 per EA (NDC 72578006206), effective Sep 30, 2026.
How has the price of VORICONAZOLE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VORICONAZOLE 50 MG TABLET has risen 41.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VORICONAZOLE 50 MG TABLET?
Since Apr 17, 2024, the NADAC for VORICONAZOLE 50 MG TABLET has ranged from a low of $0.3779 (Mar 18, 2026) to a high of $0.8275 (Sep 30, 2026), with a median of $0.4379 per EA.
Are there cheaper alternatives to VORICONAZOLE 50 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VORICONAZOLE 50 MG TABLET, is $0.5466 per EA — about 34% below VORICONAZOLE 50 MG TABLET.
Who manufactures VORICONAZOLE 50 MG TABLET?
VORICONAZOLE 50 MG TABLET (NDC 72578006206) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.